AnGes, Inc. (TYO:4563)
58.00
0.00 (0.00%)
At close: Feb 6, 2026
AnGes Revenue
AnGes had revenue of 232.00M JPY in the quarter ending September 30, 2025, with 87.10% growth. This brings the company's revenue in the last twelve months to 818.00M, up 57.01% year-over-year. In the year 2024, AnGes had annual revenue of 643.00M with 323.03% growth.
Revenue (ttm)
818.00M
Revenue Growth
+57.01%
P/S Ratio
27.58
Revenue / Employee
14.87M
Employees
55
Market Cap
22.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 643.00M | 491.00M | 323.03% |
| Dec 31, 2023 | 152.00M | 85.00M | 126.87% |
| Dec 31, 2022 | 67.00M | 3.00M | 4.69% |
| Dec 31, 2021 | 64.00M | 25.00M | 64.10% |
| Dec 31, 2020 | 39.00M | -287.00M | -88.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 6.61B |
| RaQualia Pharma | 3.05B |
| ReproCELL | 2.63B |
| Japan Tissue Engineering | 2.26B |
| Immuno-Biological Laboratories | 1.01B |
| Stella Pharma | 992.00M |
| Healios K.K. | 97.00M |
| Renascience | 87.00M |